ArticleAsian Pacific journal of cancer prevention : APJCP2020

Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types).

Maryum Nouman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.